68 related articles for article (PubMed ID: 3836843)
1. [Radioimmunoassay of the antitumor drug--methotrexate (MTX)].
Chen ZZ
Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):414-6. PubMed ID: 3836843
[TBL] [Abstract][Full Text] [Related]
2. A radioimmunoassay for methotrexate and its comparison with spectrofluorimetric procedures.
Loeffler LJ; Blum MR; Nelsen MA
Cancer Res; 1976 Sep; 36(9 pt.1):3306-11. PubMed ID: 1086132
[TBL] [Abstract][Full Text] [Related]
3. Techniques for the measurement of methotrexate in biological samples.
Aherne GW; Quinton M
Cancer Treat Rep; 1981; 65 Suppl 1():55-60. PubMed ID: 7326665
[TBL] [Abstract][Full Text] [Related]
4. A radioimmunoassay for 5-methyltetrahydrohomofolate.
Fong KL; Ho DH; Benjamin RS; Yang F; Sickler J; Brown NS; Bodey GP
J Pharmacol Exp Ther; 1981 Aug; 218(2):344-7. PubMed ID: 6265623
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase.
Iven H; Bartels H
Cancer Treat Rep; 1985; 69(7-8):825-32. PubMed ID: 4016793
[TBL] [Abstract][Full Text] [Related]
6. Rapid radioimmunoassay for methotrexate in biological fluids.
Hendel J; Sarek LJ; Hvidberg EF
Clin Chem; 1976 Jun; 22(6):813-6. PubMed ID: 945138
[TBL] [Abstract][Full Text] [Related]
7. A rapid and specific radioimmunoassay for methotrexate.
Raso V; Schreiber R
Cancer Res; 1975 Jun; 35(6):1407-10. PubMed ID: 1079473
[TBL] [Abstract][Full Text] [Related]
8. Determination of tiamenidine in biological specimens by radioimmunoassay.
Eckert HG; Baudner S; Weimer KE; Wissmann H
Arzneimittelforschung; 1981; 31(3):419-24. PubMed ID: 7194666
[TBL] [Abstract][Full Text] [Related]
9. Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate.
Gadgil SD; Damle SR; Advani SH; Vaidya AB
Cancer Treat Rep; 1982 May; 66(5):1169-71. PubMed ID: 7083219
[TBL] [Abstract][Full Text] [Related]
10. [A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy].
Miyauchi Y; Mii Y; Morishita T; Miura S; Honoki K; Aoki M; Kido A; Tamai S; Hino M; Nomura Y; Nakanishi E
Gan To Kagaku Ryoho; 1996 Apr; 23(5):595-9. PubMed ID: 8678518
[TBL] [Abstract][Full Text] [Related]
11. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system.
Mendu DR; Chou PP; Soldin SJ
Ther Drug Monit; 2007 Oct; 29(5):632-7. PubMed ID: 17898655
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay of atropine in plasma.
Wurzburger RJ; Miller RL; Boxenbaum HG; Spector S
J Pharmacol Exp Ther; 1977 Nov; 203(2):435-41. PubMed ID: 909073
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate concentrations in biological fluids: comparison of results obtained by radioimmunoassay and direct ligand binding radioassay.
Virtanen R; Iisalo E; Parvinen M; Nordman E
Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):296-302. PubMed ID: 433624
[TBL] [Abstract][Full Text] [Related]
14. Method for the determination of blood methotrexate by high performance liquid chromatography with online post-column electrochemical oxidation and fluorescence detection.
Li H; Luo W; Zeng Q; Lin Z; Luo H; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):164-8. PubMed ID: 16890029
[TBL] [Abstract][Full Text] [Related]
15. Determination of an endothelin receptor antagonist in rat plasma by radioimmunoassay.
Yuan S; Cylc D; Hsieh JY; Matuszewski BK
J Pharm Biomed Anal; 2004 Feb; 34(2):391-7. PubMed ID: 15013153
[TBL] [Abstract][Full Text] [Related]
16. Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays.
Fotoohi K; Skärby T; Söderhäll S; Peterson C; Albertioni F
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):139-44. PubMed ID: 15686977
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate and 7-hydroxymethotrexate: serum level monitoring by high-performance liquid chromatography.
Canfell C; Sadée W
Cancer Treat Rep; 1980 Jan; 64(1):165-9. PubMed ID: 7379052
[TBL] [Abstract][Full Text] [Related]
18. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
Chu BC; Fan CC; Howell SB
J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
[TBL] [Abstract][Full Text] [Related]
19. Late-onset delayed excretion of methotrexate.
Pauley JL; Panetta JC; Schmidt J; Kornegay N; Relling MV; Pui CH
Cancer Chemother Pharmacol; 2004 Aug; 54(2):146-52. PubMed ID: 15148625
[TBL] [Abstract][Full Text] [Related]
20. A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase.
Coleman DL; Canak N; Place GD; Shih C; Bowsher RR
Clin Cancer Res; 1998 Jan; 4(1):157-63. PubMed ID: 9516965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
